Aspiration & Biopsy Needles Market

Aspiration & Biopsy Needles Market by Product (Aspiration Needle, CNB, VAB), Application (Breast, Lung, Bone Cancer), Procedure (Image-guided (Ultrasound, MRI, Stereotactic), Non-image-guided), End user (Hospital, ASC, Academia) - Global Forecasts to 2027

Report Code: MD 7195 Feb, 2022, by marketsandmarkets.com

[203 Pages Report] The global aspiration and biopsy needles market is valued at an estimated USD 879 million in 2021 and is projected to reach USD 1,303 million by 2027, at a CAGR of 6.8%. Factors such as the rising prevalence of cancer, initiatives undertaken by government and global health organizations, and the increasing preference for minimally invasive procedures are the major factors driving the growth of the aspiration and biopsy needle market.

Aspiration & Biopsy Needles Market

To know about the assumptions considered for the study, Request for Free Sample Report

COVID-19 Impact on the global aspiration and biopsy needles market

The COVID-19 pandemic has resulted in significant reductions in cancer screening, cancer management visits, and cancer biopsy procedures across the globe. As a result of lockdowns, cancer screening services were disrupted to some extent, which ultimately lowered the demand for biopsy needles. The repercussions of delayed cancer detection owing to COVID-19 were investigated in a study undertaken in the UK and published in Lancet Oncology in March 2021. The study covered data from over 100,000 people with breast, colorectal, esophageal, or lung cancer. It found that 1- and 5-year cancer survival rates will be severely reduced because of the outbreak of COVID-19, owing to the reduction in diagnostic biopsies and lack of availability of screening services. However, numerous physician reports from the US have observed a growing number of screening appointments during the last quarter of 2020, which is expected to rise continually.

COVID-19 led to a significant drop in imaging procedures since March 2020 (for all modalities). A late resurgence of imaging throughput was observed in the second half of 2020; however, the overall throughput remained at a level of roughly 80% of the baseline volume for the entire year. In April 2020, the US FDA issued a guidance to provide a policy to help expand the availability and capability of medical X-ray, ultrasound, MRI systems, and image analysis software used to perform needle biopsy while mitigating the circumstances that could lead to the exposure of patients, healthcare providers, and healthcare technology management (HTM) to COVID-19.

Aspiration and Biopsy needles Market Dynamics

Drivers- Rising prevalence of cancer

Globally, there has been a significant increase in the number of people suffering from cancer. This can be attributed to a number of factors, such as lifestyle changes, unhealthy diets, and increasing tobacco consumption. According to estimates from the International Agency for Research on Cancer (IARC), in 2018, there were 17.0 million new cancer cases and 9.5 million cancer deaths worldwide. By 2040, the global burden is expected to grow to 27.5 million new cancer cases and 16.3 million cancer deaths, primarily due to the growth and aging of the population.

The incidence of cancer is the highest in more-developed regions, but mortality is relatively higher in less-developed countries due to a lack of access to treatment facilities and a lack of awareness regarding the benefits of early detection. According to the American Cancer Society, about 9.6 million people die from cancer every year, and 70% of cancer deaths occur in low-to-middle income countries such as China and India; these proportions are expected to increase further by 2025. With the rising prevalence of cancer in major regions across the globe, the demand for effective cancer diagnosis is expected to increase in the coming years. This, in turn, is expected to support the growth of the aspiration and biopsy needles market during the forecast period.

Restraint: Risk of infection associated with the use of aspiration and biopsy needles

Biopsy needle procedures, such as core-needle and fine-needle procedures, assist radiologists and surgeons in examining abnormalities at a particular site. However, patients can contract infections during these procedures as they involve cuts and incisions for removing tissue samples. Also, in several cases, aspiration and biopsy needles are reused, which further increases the risk of infection during these procedures. Even though the reuse of some needles is not recommended by healthcare authorities as well as product manufacturers, this practice is still prevalent, especially in developing countries.

Opportunity: Emerging economies

Emerging markets (such as India, China, Brazil, and Mexico) are expected to offer significant growth opportunities for players operating in the aspiration and biopsy needles market. This can be attributed to improvements in the standard of living, presence of a huge target population base (as a result of the rising prevalence of cancer), improvements and expansions in healthcare infrastructure, growing healthcare expenditure, and the modernization of healthcare research facilities in these countries. Also, the rapid economic development and increasing healthcare expenditure in these emerging countries have improved access to quality healthcare, including quality cancer care.

Challenge: Underdeveloped healthcare infrastructure and dearth of well-trained radiologists and oncologists.

With the growing awareness about different types of cancers, the demand for biopsy procedures is expected to increase in the coming years. However, there is a dearth of skilled surgeons to perform minimally invasive biopsy procedures. For instance, a shortage of more than 2,300 medical oncologists is expected in the US by 2025 (Source: Journal of Global Oncology). The effect of this factor will be more pronounced in developing and underdeveloped regions. For instance, one of the major obstacles in the delivery of care for patients with curable cancers in the Sub-Saharan African region is the dearth of medical oncologists, radiation oncologists, and other healthcare workers required for cancer care. Similarly, India is facing an acute shortage of oncologists, radiotherapists, and surgical oncologists. With 1.8 million cancer patients in the country, there is only one oncologist to treat every 2,000 patients.

Aspiration and Biopsy Needles Market Ecosystem:

Aspiration & Biopsy Needles Market by Ecosystem

To know about the assumptions considered for the study, download the pdf brochure

By product, the biopsy needles segment accounted for the largest share of the aspiration and biopsy needles market

On the basis of product, the market is segmented into aspiration and biopsy needles. The biopsy needles segment accounted for the largest share of the aspiration and biopsy needles market in 2020. This can be attributed to the rising prevalence of cancer and the increasing preference for minimally invasive diagnostic procedures (over excision biopsies).

By application, the tumor/cancer segment held the largest share of the market in 2020.

On the basis of application, the aspiration and biopsy needles market is segmented by tumor/cancer applications (breast, lung, colorectal, prostate, kidney, bone & bone marrow, and other cancers), wound applications, and other applications. In 2020, the breast cancer segment accounted for the largest share of the market. This segment is also estimated to grow at the highest CAGR during the forecast period. The large share of this segment is mainly attributed to the rising prevalence of breast cancer, growing awareness about the disease, and increasing research activity pertaining to breast screening and diagnosis.

Image-guided procedures accounted for the largest share of the aspiration and biopsy needles market, by procedure

On the basis of procedure, the aspiration and biopsy needles market is segmented into image-guided procedures (ultrasound-guided biopsy, stereotactic-guided biopsy, MRI-guided biopsy, and other image-guided procedures) and nonimage-guided procedures. Image-guided procedures accounted for the largest share of this market in 2020, primarily due to the rising preference for minimally invasive biopsy and aspiration procedures.

Asia Pacific accounted for the largest share of the aspiration and biopsy needles market in 2020

This report covers the aspiration and biopsy needles market across five major geographies-North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Asia Pacific commanded the largest share of the aspiration and biopsy needles market in 2020. Increasing initiatives by government for the cancer diagnostics and screening, rising research activity, and the high incidence of cancer in key APAC countries such as India and China are the major factors driving the growth of this regional market.

Aspiration & Biopsy Needles Market by Region

Key Market Players

CONMED Corporation (US), Medtronic Plc (Ireland), Olympus Corporation (Japan), Becton, Dickinson and Company (US), Boston Scientific Corporation (US), Cook Group Incorporated (US), Argon Medical Devices, Inc (US), INRAD Inc. (US), Somatex Medical Technologies (Germany), Stryker Corporation (US), Cardinal Health (US), Remington Medical (US), Ranfac Corporation (US), HAKKO CO., LTD (Japan), and Merit Medical Systems (US) are some of the major players in the aspiration and biopsy needles market.

Becton, Dickinson and Company (US) is a leading player in the aspiration and biopsy needles market. The company offers a wide range of biopsy products, including breast biopsy, bone marrow biopsy, and soft tissue biopsy forceps and needles. With a strong presence in North America, Europe, and APAC, the company focuses on expanding its geographic presence in emerging countries with expanding healthcare systems in Eastern Europe, the Middle East, Africa, Latin America, and certain countries within APAC. The company also focuses on inorganic strategies such as acquisitions to strengthen its product portfolio and market position. For instance, in April 2017, the company acquired C. R. Bard, Inc. (US) for USD 24 billion. It also acquired CareFusion Corporation (US) in March 2015 and positioned itself as a major player in the aspiration and biopsy needle market. These acquisitions are expected to boost the company’s presence in the market.

Get online access to the report on the World's First Market Intelligence Cloud

  • Easy to Download Historical Data & Forecast Numbers
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
Request Sample

Scope of the Report

Report Metric

Details

Market Size Available for Years

2021–2027

Base Year Considered

2020

Forecast Period

2021–2027

Currency Used

Value (USD Million)

Segments Covered

Product, Application, Procedure, End User, and Region

Geographies Covered

North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Companies Covered

15 major players, including
CONMED Corporation (US), Medtronic Plc (Ireland), Olympus Corporation (Japan), Becton, Dickinson and Company (US), Merit Medical Systems (US), Boston Scientific Corporation (US), Cook Group Incorporated (US), Argon Medical Devices, Inc (US), INRAD Inc. (US), Somatex Medical Technologies (Germany), Stryker Corporation (US), Cardinal Health (US), Remington Medical (US), HAKKO Co., Ltd (Japan), and Ranfac Corporation (US).

In this report, the aspiration and biopsy needles market has been segmented based on product, application, procedure, end user, and region.

Aspiration and biopsy needles market, by Product Type

  • Biopsy Needles
    • CNB Needles
    • VAB Needles
  • Aspiration Needles

Aspiration and biopsy needles market, by Application

  • Tumor/ Cancer Applications
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Kidney Cancer
  • Bone & Bone Marrow Cancer
  • Other Cancers
  • Wound Applications
  • Other Applications

Aspiration and biopsy needles market, by Procedure

  • Image-guided Procedures
  • Ultrasound-guided Procedures
  • Stereotactic Procedures
  • CT-guided Procedures
  • MRI-guided Procedures
  • Other Image-guided Procedures
  • Nonimage-guided Procedures

Aspiration and biopsy needles market, by End User

  • Hospitals & surgical centers
  • Diagnostic Clinics & pathology laboratories
  • Ambulatory care centers
  • Research & Academic Institutes

Aspiration and biopsy needles market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa

Recent Developments

Product Launches and Approvals

  • In December 2021, Olympus (Japan) launched the FDA 510(k)-cleared BF-UC190F endobronchial ultrasound (EBUS) bronchoscope
  • In January 2021, Hologic Inc. acquired Somatex Medical Technologies, Hologic’s strategy to provide comprehensive suite of innovative solutions across the continuum of breast health care
  • In May 2019, Argon Medical acquired Mana tech Ltd., its exclusive distributor for the UK and Ireland
  • In January 2019, IZI Medical Products acquired Cook Medical’s soft tissue biopsy and breast localization needle product line

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 26)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
    1.3 MARKETS COVERED
           FIGURE 1 ASPIRATION AND BIOPSY NEEDLES MARKET SEGMENTATION
    1.4 YEARS CONSIDERED FOR THE STUDY
    1.5 CURRENCY
           TABLE 1 STANDARD CURRENCY CONVERSION RATES
    1.6 STAKEHOLDERS
    1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 31)
    2.1 RESEARCH DATA
    2.2 RESEARCH DESIGN
           FIGURE 2 ASPIRATION AND BIOPSY NEEDLES MARKET: RESEARCH DESIGN
           2.2.1 SECONDARY RESEARCH
                    2.2.1.1 Secondary sources
           2.2.2 PRIMARY DATA
                    FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    2.3 MARKET ESTIMATION METHODOLOGY
           FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
           2.3.1 TOP-DOWN AND BOTTOM-UP APPROACHES FOR MARKET ESTIMATION
           2.3.2 REVENUE MAPPING-BASED MARKET ESTIMATION
                    FIGURE 5 ASPIRATION AND BIOPSY NEEDLES MARKET: REVENUE MAPPING-BASED MARKET ESTIMATION APPROACH
                    FIGURE 6 ASPIRATION AND BIOPSY NEEDLES MARKET: TOP-DOWN APPROACH
           2.3.3 PRIMARY RESEARCH VALIDATION
    2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
           FIGURE 7 MARKET DATA TRIANGULATION METHODOLOGY
    2.5 RESEARCH ASSUMPTIONS
    2.6 RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY (Page No. - 40)
    FIGURE 8 ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2021 VS. 2027 (USD MILLION)
    FIGURE 9 ASPIRATION AND BIOPSY NEEDLES MARKET, BY APPLICATION, 2021 VS. 2027 (USD MILLION)
    FIGURE 10 ASPIRATION AND BIOPSY NEEDLES MARKET, BY PROCEDURE, 2021 VS. 2027 (USD MILLION)
    FIGURE 11 ASPIRATION AND BIOPSY NEEDLES MARKET SHARE, BY END USER, 2021 VS. 2027
    FIGURE 12 ASPIRATION AND BIOPSY NEEDLES MARKET, BY REGION

4 PREMIUM INSIGHTS (Page No. - 45)
    4.1 ASPIRATION AND BIOPSY NEEDLES MARKET OVERVIEW
           FIGURE 13 INCREASING PREVALENCE OF CANCER ACROSS THE GLOBE IS DRIVING MARKET GROWTH
    4.2 NORTH AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2021 VS. 2027 (USD MILLION)
           FIGURE 14 BIOPSY NEEDLES SEGMENT TO HOLD MAJOR SHARE OF THE NORTH AMERICAN MARKET
    4.3 ASIA PACIFIC: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PROCEDURE, 2021 VS. 2027 (USD MILLION)
           FIGURE 15 ULTRASOUND-GUIDED PROCEDURES SEGMENT TO DOMINATE THE ASIA PACIFIC MARKET
    4.4 MEA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY APPLICATION, 2021 VS. 2027 (USD MILLION)
           FIGURE 16 BREAST CANCER APPLICATIONS SEGMENT TO DOMINATE THE MEA MARKET
    4.5 EUROPE: ASPIRATION AND BIOPSY NEEDLES MARKET, BY END USER, 2021 VS. 2027 (USD MILLION)
           FIGURE 17 HOSPITALS & SURGICAL CENTERS FORMED THE LARGEST END-USER SEGMENT IN THE EUROPEAN MARKET
    4.6 GEOGRAPHIC SNAPSHOT OF THE ASPIRATION AND BIOPSY NEEDLES MARKET
           FIGURE 18 CHINA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 50)
    5.1 MARKET DYNAMICS
           FIGURE 19 ASPIRATION AND BIOPSY NEEDLES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.1.1 DRIVERS
                    5.1.1.1 Rising prevalence of cancer
                               FIGURE 20 NUMBER OF NEW CANCER CASES (GLOBAL), 2018 VS. 2020
                    5.1.1.2 Cancer awareness initiatives undertaken by governments and global health organizations
                    5.1.1.3 Increasing preference for minimally invasive biopsies
           5.1.2 RESTRAINTS
                    5.1.2.1 Risk of infections associated with the use of aspiration and biopsy needles
                    5.1.2.2 Product recalls
                               TABLE 2 RECENT PRODUCT RECALLS BY FDA
           5.1.3 OPPORTUNITIES
                    5.1.3.1 Emerging economies
           5.1.4 CHALLENGES
                    5.1.4.1 Underdeveloped healthcare infrastructure and dearth of well-trained radiologists and oncologists
    5.2 INDUSTRY TRENDS
           5.2.1 EMERGENCE OF LIQUID BIOPSY
    5.3 VALUE CHAIN ANALYSIS
           FIGURE 21 VALUE CHAIN ANALYSIS: MAXIMUM VALUE IS ADDED DURING THE MANUFACTURING PHASE
    5.4 REGULATORY ANALYSIS
           5.4.1 NORTH AMERICA
                    5.4.1.1 US
                               TABLE 3 US FDA: MEDICAL DEVICE CLASSIFICATION
                               TABLE 4 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
                    5.4.1.2 Canada
                               TABLE 5 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
                               FIGURE 22 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES
           5.4.2 EUROPE
                    FIGURE 23 EUROPE: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES (MDR)
           5.4.3 ASIA PACIFIC
                    5.4.3.1 Japan
                               TABLE 6 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
                    5.4.3.2 China
                               TABLE 7 CHINA: CLASSIFICATION OF MEDICAL DEVICES
                    5.4.3.3 India
    5.5 PORTER’S FIVE FORCES ANALYSIS
           TABLE 8 ASPIRATION AND BIOPSY NEEDLES MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.5.1 THREAT OF NEW ENTRANTS
           5.5.2 THREAT OF SUBSTITUTES
           5.5.3 BARGAINING POWER OF SUPPLIERS
           5.5.4 BARGAINING POWER OF BUYERS
           5.5.5 DEGREE OF COMPETITION
    5.6 IMPACT OF COVID-19 ON THE ASPIRATION AND BIOPSY NEEDLES MARKET
    5.7 ECOSYSTEM COVERAGE: ASPIRATION AND BIOPSY NEEDLES MARKET
    5.8 TRADE ANALYSIS
           5.8.1 TRADE ANALYSIS FOR BIOPSY NEEDLES
                    TABLE 9 EXPORT DATA FOR BIOPSY NEEDLES, BY COUNTRY, 2018–2020 (USD MILLION)
                    TABLE 10 IMPORT DATA FOR BIOPSY NEEDLES, BY COUNTRY, 2018–2020 (USD MILLION)
    5.9 TECHNOLOGY ANALYSIS
    5.10 PATENT ANALYSIS
           FIGURE 24 TOP 10 PATENT APPLICANTS FOR ASPIRATION AND BIOPSY NEEDLES (DECEMBER 2021)
           FIGURE 25 PATENT APPLICATIONS FOR ASPIRATION AND BIOPSY NEEDLES (JANUARY 2011 TO DECEMBER 2021)
           FIGURE 26 TOP 10 PATENT APPLICANTS FOR BIOPSY NEEDLES (JANUARY 2011 TO DECEMBER 2021)
           FIGURE 27 PATENT APPLICATIONS FOR ASPIRATION NEEDLES (JANUARY 2011 TO DECEMBER 2021)

6 ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT (Page No. - 71)
    6.1 INTRODUCTION
           TABLE 11 ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
    6.2 BIOPSY NEEDLES
           TABLE 12 BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
           TABLE 13 BIOPSY NEEDLES MARKET, BY REGION, 2019–2027 (USD MILLION)
           6.2.1 BIOPSY NEEDLES MARKET SPLIT, BY PROCEDURE, 2019–2027 (USD MILLION)
                    TABLE 14 BIOPSY NEEDLES MARKET, BY PROCEDURE, 2019–2027 (USD MILLION)
           6.2.2 BIOPSY NEEDLES MARKET SPLIT, BY APPLICATION, 2019–2027 (USD MILLION)
                    TABLE 15 BIOPSY NEEDLES MARKET, BY APPLICATION, 2019–2027 (USD MILLION)
           6.2.3 BIOPSY NEEDLES MARKET SPLIT, BY END USER, 2019–2027 (USD MILLION)
                    TABLE 16 BIOPSY NEEDLES MARKET, BY END USER, 2019–2027 (USD MILLION)
           6.2.4 CORE BIOPSY NEEDLES
                    6.2.4.1 Core biopsy needles are widely used for sample collection in most prevalent cancer types
                               TABLE 17 CORE BIOPSY NEEDLES MARKET, BY REGION, 2019–2027 (USD MILLION)
           6.2.5 CORE BIOPSY NEEDLES MARKET SPLIT, BY PROCEDURE, 2019–2027 (USD MILLION)
                    TABLE 18 CORE BIOPSY NEEDLES MARKET, BY PROCEDURE, 2019–2027 (USD MILLION)
           6.2.6 CORE BIOPSY NEEDLES MARKET SPLIT, BY APPLICATION, 2019–2027 (USD MILLION)
                    TABLE 19 CORE BIOPSY NEEDLES MARKET, BY APPLICATION, 2019–2027 (USD MILLION)
           6.2.7 CORE BIOPSY NEEDLES MARKET SPLIT, BY END USER, 2019–2027 (USD MILLION)
                    TABLE 20 CORE BIOPSY NEEDLES MARKET, BY END USER, 2019–2027 (USD MILLION)
           6.2.8 VACUUM-ASSISTED BIOPSY NEEDLES
                    6.2.8.1 High-volume sampling and greater specificity of VAB procedures to drive the growth of this market segment
                               TABLE 21 VACUUM-ASSISTED BIOPSY NEEDLES MARKET, BY REGION, 2019–2027 (USD MILLION)
           6.2.9 VACUUM-ASSISTED BIOPSY NEEDLES MARKET SPLIT, BY PROCEDURE, 2019–2027 (USD MILLION)
                    TABLE 22 VACUUM-ASSISTED BIOPSY NEEDLES MARKET, BY PROCEDURE, 2019–2027 (USD MILLION)
           6.2.10 VACUUM-ASSISTED BIOPSY NEEDLES MARKET SPLIT, BY APPLICATION, 2019–2027 (USD MILLION)
                    TABLE 23 VACUUM-ASSISTED BIOPSY NEEDLES MARKET, BY APPLICATION, 2019–2027 (USD MILLION)
           6.2.11 VACUUM-ASSISTED BIOPSY NEEDLES MARKET SPLIT, BY END USER, 2019–2027 (USD MILLION)
                    TABLE 24 VACUUM-ASSISTED BIOPSY NEEDLES MARKET, BY END USER, 2019–2027 (USD MILLION)
    6.3 ASPIRATION NEEDLES
           6.3.1 ASPIRATION NEEDLES ARE ESTIMATED TO ACCOUNT FOR A SMALLER SHARE OF THE MARKET
                    TABLE 25 ASPIRATION NEEDLES MARKET, BY REGION, 2019–2027 (USD MILLION)
           6.3.2 ASPIRATION NEEDLES MARKET SPLIT, BY PROCEDURE, 2019–2027 (USD MILLION)
                    TABLE 26 ASPIRATION NEEDLES MARKET, BY PROCEDURE, 2019–2027 (USD MILLION)
           6.3.3 ASPIRATION NEEDLES MARKET SPLIT, BY APPLICATION, 2019–2027 (USD MILLION)
                    TABLE 27 ASPIRATION NEEDLES MARKET, BY APPLICATION, 2019–2027 (USD MILLION)
           6.3.4 ASPIRATION NEEDLES MARKET SPLIT, BY END USER, 2019–2027 (USD MILLION)
                    TABLE 28 ASPIRATION NEEDLES MARKET, BY END USER, 2019–2027 (USD MILLION)

7 ASPIRATION AND BIOPSY NEEDLES MARKET, BY PROCEDURE (Page No. - 83)
    7.1 INTRODUCTION
           TABLE 29 ASPIRATION AND BIOPSY NEEDLES MARKET, BY PROCEDURE, 2019–2027 (USD MILLION)
    7.2 IMAGE-GUIDED PROCEDURES
           TABLE 30 ASPIRATION AND BIOPSY NEEDLES MARKET FOR IMAGE-GUIDED PROCEDURES, BY TYPE, 2019–2027 (USD MILLION)
           7.2.1 ULTRASOUND-GUIDED PROCEDURES
                    7.2.1.1 Ultrasound imaging is the preferred imaging standard for most common cancer types
                               TABLE 31 ASPIRATION AND BIOPSY NEEDLES MARKET FOR ULTRASOUND-GUIDED PROCEDURES, BY REGION, 2019–2027 (USD MILLION)
           7.2.2 STEREOTACTIC PROCEDURES
                    7.2.2.1 Stereotactic procedures are still considered the global standard in biopsies
                               TABLE 32 ASPIRATION AND BIOPSY NEEDLES MARKET FOR STEREOTACTIC PROCEDURES, BY REGION, 2019–2027 (USD MILLION)
           7.2.3 CT-GUIDED PROCEDURES
                    7.2.3.1 CT imaging is the preferred imaging standard for lung and liver cancers
                               TABLE 33 ASPIRATION AND BIOPSY NEEDLES MARKET FOR CT-GUIDED PROCEDURES, BY REGION, 2019–2027 (USD MILLION)
           7.2.4 MRI-GUIDED PROCEDURES
                    7.2.4.1 MRI imaging is the preferred imaging standard for several common cancer types
                               TABLE 34 ASPIRATION AND BIOPSY NEEDLES MARKET FOR MRI-GUIDED PROCEDURES, BY REGION, 2019–2027 (USD MILLION)
           7.2.5 OTHER IMAGE-GUIDED PROCEDURES
                    TABLE 35 ASPIRATION AND BIOPSY NEEDLES MARKET FOR OTHER IMAGE-GUIDED PROCEDURES, BY REGION, 2019–2027 (USD MILLION)
    7.3 NON-IMAGE-GUIDED PROCEDURES
           7.3.1 NON-IMAGE-GUIDED PROCEDURES SEGMENT TO ACCOUNT FOR A SMALLER SHARE OF THE MARKET
                    TABLE 36 ASPIRATION AND BIOPSY NEEDLES MARKET FOR NON-IMAGE-GUIDED PROCEDURES, BY REGION, 2019–2027 (USD MILLION)

8 ASPIRATION AND BIOPSY NEEDLES MARKET, BY APPLICATION (Page No. - 92)
    8.1 INTRODUCTION
           TABLE 37 ASPIRATION AND BIOPSY NEEDLES MARKET, BY APPLICATION, 2019–2027 (USD MILLION)
    8.2 TUMOR/CANCER APPLICATIONS
           TABLE 38 ASPIRATION AND BIOPSY NEEDLES MARKET FOR TUMOR/CANCER APPLICATIONS, BY TYPE, 2019–2027 (USD MILLION)
           8.2.1 BREAST CANCER
                    8.2.1.1 Increasing awareness of breast cancer to drive the growth of this market segment
                               TABLE 39 ASPIRATION AND BIOPSY NEEDLES MARKET FOR BREAST CANCER, BY REGION, 2019–2027 (USD MILLION)
           8.2.2 LUNG CANCER
                    8.2.2.1 Growing prevalence of lung cancer to support the growth of this market segment
                               TABLE 40 ASPIRATION AND BIOPSY NEEDLES MARKET FOR LUNG CANCER, BY REGION, 2019–2027 (USD MILLION)
           8.2.3 COLORECTAL CANCER
                    8.2.3.1 Advancements in alternative diagnosis techniques to reduce the adoption of colorectal biopsy needles
                               TABLE 41 ASPIRATION AND BIOPSY NEEDLES MARKET FOR COLORECTAL CANCER, BY REGION, 2019–2027 (USD MILLION)
           8.2.4 PROSTATE CANCER
                    8.2.4.1 Availability of funds for prostate cancer research by different government authorities to support the growth of this market segment
                               TABLE 42 ASPIRATION AND BIOPSY NEEDLES MARKET FOR PROSTATE CANCER, BY REGION, 2019–2027 (USD MILLION)
           8.2.5 KIDNEY CANCER
                    8.2.5.1 Rising prevalence of kidney cancer to support the growth of this market segment
                               TABLE 43 ASPIRATION AND BIOPSY NEEDLES MARKET FOR KIDNEY CANCER, BY REGION, 2019–2027 (USD MILLION)
           8.2.6 BONE & BONE MARROW CANCER
                    8.2.6.1 Rising incidence of bone cancer to fuel the growth of this market segment
                               TABLE 44 ASPIRATION AND BIOPSY NEEDLES MARKET FOR BONE & BONE MARROW CANCER, BY REGION, 2019–2027 (USD MILLION)
           8.2.7 OTHER CANCERS
                    TABLE 45 ASPIRATION AND BIOPSY NEEDLES MARKET FOR OTHER CANCERS, BY REGION, 2019–2027 (USD MILLION)
    8.3 WOUND APPLICATIONS
           8.3.1 THE DEMAND FOR WOUND BIOPSIES IS EXPECTED TO INCREASE WITH THE INCREASE IN PREVALENCE OF DIABETIC FOOT ULCERS
                    TABLE 46 ASPIRATION AND BIOPSY NEEDLES MARKET FOR WOUND APPLICATIONS, BY REGION, 2019–2027 (USD MILLION)
    8.4 OTHER APPLICATIONS
           TABLE 47 ASPIRATION AND BIOPSY NEEDLES MARKET FOR OTHER APPLICATIONS, BY REGION, 2019–2027 (USD MILLION)

9 ASPIRATION AND BIOPSY NEEDLES MARKET, BY END USER (Page No. - 103)
    9.1 INTRODUCTION
           TABLE 48 ASPIRATION AND BIOPSY NEEDLES MARKET, BY END USER, 2019–2027 (USD MILLION)
    9.2 HOSPITALS & SURGICAL CENTERS
           9.2.1 HOSPITALS AND SURGICAL CENTERS ARE THE LARGEST END USERS OF ASPIRATION AND BIOPSY NEEDLES
                    TABLE 49 ASPIRATION AND BIOPSY NEEDLES MARKET FOR HOSPITALS & SURGICAL CENTERS, BY REGION, 2019–2027 (USD MILLION)
    9.3 AMBULATORY CARE CENTERS
           9.3.1 PREFERENCE FOR NEEDLE BIOPSIES IN AMBULATORY CARE CENTERS IS INCREASING DUE TO ONE-DAY OUTPATIENT SURGERY TIMELINES
                    TABLE 50 ASPIRATION AND BIOPSY NEEDLES MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2019–2027 (USD MILLION)
    9.4 DIAGNOSTIC CLINICS & PATHOLOGY LABORATORIES
           9.4.1 A MAJORITY OF SAMPLE DIAGNOSIS IS PERFORMED BY DIAGNOSTIC/PATHOLOGY LABORATORIES
                    TABLE 51 ASPIRATION AND BIOPSY NEEDLES MARKET FOR DIAGNOSTIC CLINICS & PATHOLOGY LABORATORIES, BY REGION, 2019–2027 (USD MILLION)
    9.5 RESEARCH & ACADEMIC INSTITUTES
           9.5.1 MARKET FOR BIOPSY NEEDLES IN RESEARCH & ACADEMIC INSTITUTES IS EXPECTED TO GROW WITH GROWTH IN CANCER RESEARCH
                    TABLE 52 ASPIRATION AND BIOPSY NEEDLES MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2019–2027 (USD MILLION)

10 ASPIRATION AND BIOPSY NEEDLES MARKET, BY REGION (Page No. - 109)
     10.1 INTRODUCTION
             TABLE 53 ASPIRATION AND BIOPSY NEEDLES MARKET, BY REGION, 2019–2027 (USD MILLION)
     10.2 ASIA PACIFIC
             FIGURE 28 ASIA PACIFIC: ASPIRATION AND BIOPSY NEEDLES MARKET SNAPSHOT
             TABLE 54 ASIA PACIFIC: ASPIRATION AND BIOPSY NEEDLES MARKET, BY COUNTRY, 2019–2027 (USD MILLION)
             TABLE 55 ASIA PACIFIC: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
             TABLE 56 ASIA PACIFIC: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
             TABLE 57 ASIA PACIFIC: ASPIRATION AND BIOPSY NEEDLES MARKET, BY APPLICATION, 2019–2027 (USD MILLION)
             TABLE 58 ASIA PACIFIC: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PROCEDURE, 2019–2027 (USD MILLION)
             TABLE 59 ASIA PACIFIC: ASPIRATION AND BIOPSY NEEDLES MARKET, BY END USER, 2019–2027 (USD MILLION)
             10.2.1 CHINA
                        10.2.1.1 China is the largest market for aspiration and biopsy needles in APAC
                                     TABLE 60 CHINA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
                                     TABLE 61 CHINA: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
             10.2.2 JAPAN
                        10.2.2.1 Japan is the second-largest market for aspiration and biopsy needles in APAC
                                     TABLE 62 JAPAN: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
                                     TABLE 63 JAPAN: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
             10.2.3 INDIA
                        10.2.3.1 Improving healthcare infrastructure to drive market growth in India
                                     TABLE 64 INDIA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
                                     TABLE 65 INDIA: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
             10.2.4 SOUTH KOREA
                        10.2.4.1 Growing healthcare expenditure to drive market growth in South Korea
                                     TABLE 66 SOUTH KOREA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
                                     TABLE 67 SOUTH KOREA: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
             10.2.5 AUSTRALIA
                        10.2.5.1 Increasing prevalence of cancer to drive market growth in Australia
                                     TABLE 68 AUSTRALIA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
                                     TABLE 69 AUSTRALIA: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
             10.2.6 REST OF ASIA PACIFIC
                        TABLE 70 ROAPAC: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
                        TABLE 71 ROAPAC: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
     10.3 EUROPE
             TABLE 72 EUROPE: ASPIRATION AND BIOPSY NEEDLES MARKET, BY COUNTRY, 2019–2027 (USD MILLION)
             TABLE 73 EUROPE: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
             TABLE 74 EUROPE: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
             TABLE 75 EUROPE: ASPIRATION AND BIOPSY NEEDLES MARKET, BY APPLICATION, 2019–2027 (USD MILLION)
             TABLE 76 EUROPE: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PROCEDURE, 2019–2027 (USD MILLION)
             TABLE 77 EUROPE: ASPIRATION AND BIOPSY NEEDLES MARKET, BY END USER, 2019–2027 (USD MILLION)
             10.3.1 GERMANY
                        10.3.1.1 Higher per capita spending on healthcare and presence of notable players to drive market growth in Germany
                                     TABLE 78 GERMANY: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
                                     TABLE 79 GERMANY: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
             10.3.2 FRANCE
                        10.3.2.1 Increasing prevalence of cancer to drive market growth in France
                                     TABLE 80 FRANCE: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
                                     TABLE 81 FRANCE: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
             10.3.3 UK
                        10.3.3.1 Higher per capita spending on healthcare and the presence of notable players are expected to support market growth in the UK
                                     TABLE 82 UK: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
                                     TABLE 83 UK: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
             10.3.4 ITALY
                        10.3.4.1 Increasing geriatric population to drive market growth in Italy
                                     TABLE 84 ITALY: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
                                     TABLE 85 ITALY: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
             10.3.5 SPAIN
                        10.3.5.1 Growing prevalence of cancer to drive market growth in Spain
                                     TABLE 86 SPAIN: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
                                     TABLE 87 SPAIN: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
             10.3.6 REST OF EUROPE
                        TABLE 88 ROE: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
                        TABLE 89 ROE: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
     10.4 NORTH AMERICA
             FIGURE 29 NORTH AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET SNAPSHOT
             TABLE 90 NORTH AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY COUNTRY, 2019–2027 (USD MILLION)
             TABLE 91 NORTH AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
             TABLE 92 NORTH AMERICA: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
             TABLE 93 NORTH AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY APPLICATION, 2019–2027 (USD MILLION)
             TABLE 94 NORTH AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PROCEDURE, 2019–2027 (USD MILLION)
             TABLE 95 NORTH AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY END USER, 2019–2027 (USD MILLION)
             10.4.1 US
                        10.4.1.1 The US dominates the North American aspiration and biopsy needles market
                                     TABLE 96 US: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
                                     TABLE 97 US: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
             10.4.2 CANADA
                        10.4.2.1 Growing incidence of cancer to drive market growth in Canada
                                     TABLE 98 CANADA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
                                     TABLE 99 CANADA: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
     10.5 LATIN AMERICA
             TABLE 100 LATIN AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY COUNTRY, 2019–2027 (USD MILLION)
             TABLE 101 LATIN AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
             TABLE 102 LATIN AMERICA: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
             TABLE 103 LATIN AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY APPLICATION, 2019–2027 (USD MILLION)
             TABLE 104 LATIN AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PROCEDURE, 2019–2027 (USD MILLION)
             TABLE 105 LATIN AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY END USER, 2019–2027 (USD MILLION)
             10.5.1 BRAZIL
                        10.5.1.1 Brazil is the largest market for aspiration and biopsy needles in LATAM
                                     TABLE 106 BRAZIL: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
                                     TABLE 107 BRAZIL: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
             10.5.2 MEXICO
                        10.5.2.1 Increasing healthcare spending to drive market growth in Mexico
                                     TABLE 108 MEXICO: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
                                     TABLE 109 MEXICO: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
             10.5.3 REST OF LATIN AMERICA
                        TABLE 110 ROLA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
                        TABLE 111 ROLA: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
     10.6 MIDDLE EAST & AFRICA
             10.6.1 INCREASING PREVALENCE OF CANCER TO DRIVE MARKET GROWTH IN MEA
                        TABLE 112 MIDDLE EAST & AFRICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION)
                        TABLE 113 MIDDLE EAST & AFRICA: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION)
                        TABLE 114 MIDDLE EAST & AFRICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY APPLICATION, 2019–2027 (USD MILLION)
                        TABLE 115 MIDDLE EAST & AFRICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PROCEDURE, 2019–2027 (USD MILLION)
                        TABLE 116 MIDDLE EAST & AFRICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY END USER, 2019–2027 (USD MILLION)

`
     11.1 OVERVIEW
     11.2 KEY PLAYER STRATEGIES
     11.3 MARKET SHARE ANALYSIS: ASPIRATION AND BIOPSY NEEDLES MARKET, BY KEY PLAYER (2020)
             FIGURE 30 BECTON, DICKINSON AND COMPANY HELD THE LEADING POSITION IN THE ASPIRATION AND BIOPSY NEEDLES MARKET IN 2020
     11.4 COMPANY EVALUATION QUADRANT FOR 25 MAJOR PLAYERS (2020)
             11.4.1 STARS
             11.4.2 EMERGING LEADERS
             11.4.3 PERVASIVE PLAYERS
             11.4.4 PARTICIPANTS
                        FIGURE 31 ASPIRATION AND BIOPSY NEEDLES MARKET: COMPETITIVE LEADERSHIP MAPPING, 2020
     11.5 COMPANY EVALUATION QUADRANT FOR START-UPS/SMES (2020)
             11.5.1 PROGRESSIVE COMPANIES
             11.5.2 RESPONSIVE COMPANIES
             11.5.3 DYNAMIC COMPANIES
             11.5.4 STARTING BLOCKS
                        FIGURE 32 ASPIRATION AND BIOPSY NEEDLES MARKET: COMPETITIVE LEADERSHIP MAPPING FOR SMES/START-UPS (2020)
     11.6 COMPETITIVE BENCHMARKING
             TABLE 117 APPLICATION FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE ASPIRATION AND BIOPSY NEEDLES MARKET
             TABLE 118 REGIONAL FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE ASPIRATION AND BIOPSY NEEDLES MARKET
     11.7 COMPETITIVE SCENARIO (2018–2021)
             11.7.1 NEW PRODUCT LAUNCHES AND APPROVALS
             11.7.2 DEALS

12 COMPANY PROFILES (Page No. - 155)
     12.1 INTRODUCTION
     12.2 KEY PLAYERS
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)* 
             12.2.1 BECTON, DICKINSON AND COMPANY (BD)
                        TABLE 119 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
                        FIGURE 33 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2021)
             12.2.2 MERIT MEDICAL SYSTEMS
                        TABLE 120 MERIT MEDICAL SYSTEMS: BUSINESS OVERVIEW
                        FIGURE 34 MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT (2020)
             12.2.3 COOK GROUP INCORPORATED
                        TABLE 121 COOK GROUP INCORPORATED: BUSINESS OVERVIEW
             12.2.4 OLYMPUS CORPORATION
                        TABLE 122 OLYMPUS CORPORATION: BUSINESS OVERVIEW
                        FIGURE 35 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2021)
             12.2.5 MEDTRONIC, PLC
                        TABLE 123 MEDTRONIC, PLC: BUSINESS OVERVIEW
                        FIGURE 36 MEDTRONIC, PLC: COMPANY SNAPSHOT (2020)
             12.2.6 ARGON MEDICAL DEVICES, INC.
                        TABLE 124 ARGON MEDICAL DEVICES, INC: BUSINESS OVERVIEW
             12.2.7 BOSTON SCIENTIFIC CORPORATION
                        TABLE 125 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW
                        FIGURE 37 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2020)
             12.2.8 CARDINAL HEALTH, INC.
                        TABLE 126 CARDINAL HEALTH, INC.: BUSINESS OVERVIEW
                        FIGURE 38 CARDINAL HEALTH, INC.: COMPANY SNAPSHOT (2021)
             12.2.9 CONMED CORPORATION
                        TABLE 127 CONMED CORPORATION: BUSINESS OVERVIEW
                        FIGURE 39 CONMED CORPORATION: COMPANY SNAPSHOT (2020)
             12.2.10 HAKKO CO., LTD.
                        TABLE 128 HAKKO CO., LTD.: BUSINESS OVERVIEW
             12.2.11 INRAD INC.
                        TABLE 129 INRAD INC.: BUSINESS OVERVIEW
             12.2.12 RANFAC CORPORATION
                        TABLE 130 RANFAC CORPORATION: BUSINESS OVERVIEW
             12.2.13 REMINGTON MEDICAL INC.
                        TABLE 131 REMINGTON MEDICAL INC.: BUSINESS OVERVIEW
             12.2.14 SOMATEX MEDICAL TECHNOLOGIES
                        TABLE 132 SOMATEX MEDICAL TECHNOLOGIES: BUSINESS OVERVIEW
             12.2.15 STRYKER CORPORATION
                        TABLE 133 STRYKER CORPORATION: BUSINESS OVERVIEW
                        FIGURE 40 STRYKER CORPORATION: COMPANY SNAPSHOT (2020)
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies. 
     12.3 OTHER PLAYERS
             12.3.1 CREGANNA
             12.3.2 STERYLAB SRL
             12.3.3 DR. JAPAN CO., LTD.
             12.3.4 DTR MEDICAL
             12.3.5 ISCON SURGICALS LTD.
             12.3.6 JOHNSON & JOHNSON MEDICAL DEVICES
             12.3.7 SHANGHAI SA MEDICAL & PLASTIC INSTRUMENTS
             12.3.8 MEDAX MEDICAL DEVICES
             12.3.9 MEDITECH DEVICES
             12.3.10 WELLGO MEDICAL PRODUCTS GMBH

13 APPENDIX (Page No. - 197)
     13.1 DISCUSSION GUIDE
     13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     13.3 AVAILABLE CUSTOMIZATIONS
     13.4 RELATED REPORTS
     13.5 AUTHOR DETAILS

This study involved four major activities in estimating the current size of the aspiration and biopsy needles market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and the parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation processes were used to estimate the market size of segments and subsegments.

Secondary Research

Secondary research was conducted to obtain key information about the market classification and segmentation, geographical scenario, key developments undertaken by major market players, and the identification of key industry trends. The secondary sources used for this study include annual reports, press releases, and investor presentations of companies; white papers; certified publications; and articles from recognized websites, databases, and directories.

Primary Research

Extensive primary research was conducted after acquiring a preliminary understanding of the aspiration and biopsy needles market scenario through secondary research. Primary interviews were conducted with market experts from both the demand-side (such as department heads at hospitals, oncologists, radiologists, and diagnostic centers) and supply-side respondents (such as C & D-level executives & product managers of key manufacturers, distributors, and channel partners) across North America, Europe, Asia Pacific, Latin America and Middle East & Africa. Approximately 30% and 70% of primary interviews were conducted with both the demand- and supply-side respondents, respectively. Primary data was collected through questionnaires, e-mails, online surveys, and telephonic interviews. A breakdown of primary respondents is provided below:

Aspiration & Biopsy Needles Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Estimation Methodology

  • A detailed market estimation approach was followed to estimate and validate the size of the aspiration and biopsy needles market and other dependent submarkets.
  • The key players in the aspiration and biopsy needles market were identified through secondary research, and their global market shares were determined through primary and secondary research.
  • The research methodology includes the study of the annual and quarterly financial reports of top market players as well as interviews with industry experts to gather key insights on various market segments and subsegments.
  • All segmental shares, splits, and breakdowns were determined using secondary sources and verified through primary sources.
  • Major Macroindicators in play have been accounted for, viewed in detail, verified through primary research, and analyzed to understand their impact on market growth and various segments and subsegments.
  • The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

Aspiration & Biopsy Needles Market Size, and Methodology

Data Triangulation:

After deriving the overall aspiration and biopsy needles market value from the market size estimation process explained above, the total market value data was split into several segments and subsegments. Data triangulation and market breakdown procedures were undertaken to complete the overall market engineering process and arrive at the exact statistics for all segments, wherever applicable. The data was triangulated by studying various qualitative & quantitative variables as well as by analyzing regional trends for both the demand- and supply-side macroindicators.

Report Objectives:

  • To define, describe, and forecast the aspiration and biopsy needles market on the basis of product, site, procedure, end user, and region
  • To provide detailed information regarding the major factors influencing the aspiration and biopsy needles market (such as drivers, restraints, opportunities, and industry-specific challenges)
  • To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the aspiration and biopsy needles market.
  • To analyze key growth opportunities in the aspiration and biopsy needles market for key stakeholders and provide details of the competitive landscape for key market players
  • To forecast the market value of various segments and/or subsegments with respect to four major regional segments—North America, Europe, Asia Pacific, and the Rest of the World
  • To profile the key players in the aspiration and biopsy needles market and comprehensively analyze their market shares and core competencies
  • To track and analyze competitive developments undertaken by major players in the aspiration and biopsy needles market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the aspiration and biopsy needles market report:

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of the top five companies in the aspiration and biopsy needles market.

Company Information

  • Detailed analysis and profiling of additional market players (up to 5)

Geographic Analysis

  • Further breakdown of the Rest of Europe aspiration and biopsy needles market into Belgium, Austria, the Czech Republic, Denmark, Greece, Poland, and Russia, among other
  • Further breakdown of the Rest of Asia Pacific aspiration and biopsy needles market into wan, New Zealand, Vietnam, the Philippines, Singapore, Malaysia, Thailand, and Indonesia among other
  • Further breakdown of the Latin American aspiration and biopsy needles market into Argentina, Chile, Peru, and Colombia, among other
Report Code
MD 7195
Published ON
Feb, 2022
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Aspiration & Biopsy Needles Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2022 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback